McKinsey, Opioids, & Ethics
CaseInterview.com
FEBRUARY 10, 2021
A couple of weeks ago, McKinsey settled a major lawsuit regarding the firm’s work with the manufacturer of OxyContin — one of the key drugs in the opioid crisis that has claimed many lives. The settlement was for close to $600 million, as reported by the New York Times. Here are my thoughts…. First, I’m beyond disappointed in McKinsey’s role in furthering the opioid epidemic.
Let's personalize your content